Average Co-Inventor Count = 6.40
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sugen Incorporated (6 from 157 patents)
2. Pharmacia & Upjohn Company (2 from 523 patents)
3. Other (1 from 832,880 patents)
4. Astrazeneca Ab (1 from 1,500 patents)
5. Agouron Pharmaceuticals, Inc. (1 from 174 patents)
9 patents:
1. 8088784 - 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
2. 7582756 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
3. 7256189 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
4. 7186832 - Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
5. 7179910 - 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
6. 7157460 - Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
7. 6777417 - 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
8. 6653308 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
9. 6642232 - 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors